Author: Eric Barber

Facing ongoing challenges with drug shortages and quality problems, the pharmaceutical industry seeks robust solutions. FDA’s Quality Management Maturity (QMM) initiative offers a promising pathway. By focusing on four key pillars, including sustainability, risk management, regulatory compliance, and quality culture, the QMM initiative aims to elevate the entire manufacturing chain’s reliability and quality. Embracing these… Continue reading QMM for Pharmaceutical Manufacturers– Implications for Drug Manufacturers, API Suppliers and Contract Manufacturers

<![if !vml]> <![endif]> Home U.S.-based consulting firm providing compliance and remediation expertise in scientific, technical, regulatory affairs, and management to public and private sector organizations. August 7, 2023 Indian Govt sets deadline for Pharma GMP Compliance Adopt WHO-standard good manufacturing practices (GMP) within One Year The Indian government has set a deadline for mandatory implementation… Continue reading Indian Government sets deadline for Pharma GMP Compliance